Patent 7378515 was granted and assigned to Geneart AG on May, 2008 by the United States Patent and Trademark Office.
The present invention relates to synthetic gag and gagpol genes optimized for high level expression via codon optimization and the uses thereof for the efficient generation of vector particles. The invention further relates to the generation of packaging cells and vaccines based on the synthetic gag and gagpol genes.